Pontifícia Universidade Católica Do Rio De Janeiro

This early-phase trial investigates whether psilocybin, the active compound in magic mushrooms, can alter self-awareness in healthy adults. One hundred participants will receive either 15 mg of psilocybin or an active placebo (niacin) and complete tasks measuring metacognition an…